Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • PropTech • IT (& TMT) • Hospitality (& Events) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Early Stage, Expansion,Seed,Later, Series A, Series B, Venture, Convertible Note |
Investing | United States • United Kingdom • France • Switzerland • Europe |
Investment Range | $100,000 - $50,000,000 |
Investment Sweet Spot | $15,000,000 |
Assets Under Management | $1,200,000,000 |
Index Ventures is a venture capital firm which specializes in seed, early stage, later stage and growth capital investments. The firm focuses on investing in companies based in Europe, operating in the biotechnology, retail, clean technology, media and life sciences sectors. It was founded in 1996 and is based in Geneva, Switzerland.
Index Ventures invests in multi-stage, transformative companies who are willing to challenge convention. The firm is especially dedicated to the information technology, clean technology, and life science sectors. They back the best and most ambitious entrepreneurs with a tight-knit collaborative partnership that retains a shared mission of seeing opportunity instead of obstacles. Index Ventures has teamed up with exceptional entrepreneurs in 39 cities around the world and have helped them grow into new regions. They provide a full-service partnership where they bring a lot of experience and expertise to the table.
In November 2022, they launched their second seed fund Origin II, a $300M fund focus on early-stage investing. It is $100m larger than Origin I, and is a highly collaborative fund, with seed-specific support, that works alongside solo GPs and angels, to help companies be best positioned for success.